Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 121 - 135 of 518 items.
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
AlertPublic advisory | 2022-04-21
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
AlertHealth professional risk communication | 2022-04-14
Health Canada warns Canadians that a Vertbaudet children’s bathrobe poses a flammability hazard
AlertPublic advisory | 2022-04-05
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
Ranitidine products recalled because of a nitrosamine impurity
AlertInformation update | 2022-03-11
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
AlertPublic advisory | 2022-03-01
Rapid antigen test kits and potential exposure to hazardous substances
AlertPublic advisory | 2022-02-24
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03